Several studies on the use of TPN and bowel rest in Crohn's disease have reported favourable results' but most involved small numbers of patients or lacked controls. Moreover, the mechanisms by which such therapy might contribute to the improvement in patients with Crohn's disease is unknown. The large caloric loads and weight gain may not be critical as comparable success in inducing remissions has been observed while maintaining positive nitrogen balance in the absence of an exogenous source of calories. 8 Alternatively, the role of complete bowel rest has recently been questioned in a small but controlled study by Lochs et al9 where TPN with oral food was as efficacious in reducing the activity of Crohn's disease as TPN and nothing by mouth. Two prospective controlled trials' "1 have further indicated that elemental diets, which provide only partial bowel rest, achieves a remission rate in active Crohn's disease comparable with that of daily administration of prednisolone, although in each study the patient population receiving prednisolone had not pre-1309 viously been refractory to drug therapy. Should comparable clinical and nutritional improvement occur in patients refractory to drug therapy without utilising complete bowel rest, then elemental diets might be preferable to TPN because the former are associated with fewer complications and are less expensive.
The present study was therefore designed to distinguish the beneficial effects of nutritional support and bowel rest as independent variables in the management of hospitalised patients with active Crohn's disease unresponsive to conventional drug treatment and in whom intestinal resection was considered the only other therapeutic alternative. This was undertaken by randomly and prospectively assigning patients to one of three groups: TPN (ii) a progressive increase in CDAI to greater than 250 occurred by the end of the first week of therapy; (iii) there was no improvement in CDAI after two weeks of therapy; (iv) there was significant pain or vomiting over any three consecutive days; (v) the mean daily caloric intake after seven days did not achieve 1000 calories in the PPN group; (vi) the mean daily caloric input after seven days did not achieve 2000 calories in the DFD group.
All patients considered to have successfully undergone remission were discharged from hospital on prednisone which was tapered to a maintenance dose of 15 mg/daily and were followed at one, three, six and 12 months. A The design of the present study was specifically directed towards testing independently the role of bowel rest in contradistinction to nutritional support. Our data argue against bowel rest being a major factor contributing to an initial remission in patients with active Crohn's disease. The alternative possibility, however, namely whether there is a beneficial role for nutritional repletion, either through the enteral or the parenteral route, has also received little attention. Harries et al`7 in a controlled, crossover prospective study with malnourished Crohn's patients found significant clinical and biochemical improvement following the addition of an enteral non-elemental liquid supplement to an ordinary diet, although the nutritional factor(s) that might facilitate a remission were not defined and continue to remain speculative. Cell immunity is improved by nutritional repletion in patients with protein-calorie malnutrition'8 and could indirectly contribute to a reduction in disease activity. Alternatively, the provision of essential nutrients, such as glutamine, which influences the metabolism and differentiation of epithelial tissue'9 might enhance repair of diseased mucosa. Definition of the role of providing nutrition, per se, for patients with active Crohn's disease, using controlled trials remains an area for further investigation.
As implied from previous uncontrolled data,20 the present study confirms that an enteral defined formula diet was as efficacious as total parenteral nutrition in achieving remission in patients with active Crohn's disease. Enteral systems may therefore be preferable to TPN in the nutritional management of Crohn's patients given the simpler administration, at a lower cost2' and generally with fewer complications.
Two independent controlled trials have addressed 
